Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer.

Front Nucl Med · 2023 · PMC11460297 · PMID 39380961

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

Scratch/wound healing assay After 24 h incubation with IONs-PSMA, IONs-BN, and IONs-PSMA/BN, PC3 cells present an extremely significant WC increase of ∼30%–40%, comparable to the control, while IONs-SH present a significant increase of 21%.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.